Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-12 Sale | 2024-12-13 7:53 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,605 | $12.23 | $1,768,093 | 310,888 (Direct) | View |
| 2024-12-10 Sale | 2024-12-12 5:41 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 50,000 | $13.15 | $657,625 | 136,380 (Direct) | View |
| 2024-12-04 Sale | 2024-12-06 7:15 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,640 | $14.11 | $2,041,200 | 436,020 (Direct) | View |
| 2024-12-02 Sale | 2024-12-04 9:45 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 90,000 | $13.43 | $1,208,619 | 334,280 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 4:11 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 100,000 | $14.12 | $1,411,742 | 136,380 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-12 Exercise | 2024-12-13 7:53 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 117,333 | $0.84 | 310,888 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-13 7:53 pm | N/A 2029-07-04 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,605 | $0 | 310,888 (Direct) | View |
| 2024-12-13 Exercise | 2024-12-13 7:53 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 27,272 | $1.44 | 310,888 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:41 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 50,000 | $0.84 | 136,380 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:41 pm | N/A 2029-07-04 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 50,000 | $0 | 136,380 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 7:15 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,640 | $0.84 | 436,020 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 7:15 pm | N/A 2029-07-04 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,640 | $0 | 436,020 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-04 9:45 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 90,000 | $0.84 | 334,280 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-04 9:45 pm | N/A 2029-12-16 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 90,000 | $0 | 334,280 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:41 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:00 pm | N/A 2033-01-02 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 165,000 | $0 | 165,000 (Direct) | View |
| 2022-11-08 Option Award | 2022-11-10 6:00 pm | N/A 2029-07-05 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 603,753 | $0 | 840,133 (Direct) | View |